AT375338B - Verfahren zur herstellung von neuen polypeptiden oder von deren saeureadditionssalzen - Google Patents

Verfahren zur herstellung von neuen polypeptiden oder von deren saeureadditionssalzen

Info

Publication number
AT375338B
AT375338B AT0634679A AT634679A AT375338B AT 375338 B AT375338 B AT 375338B AT 0634679 A AT0634679 A AT 0634679A AT 634679 A AT634679 A AT 634679A AT 375338 B AT375338 B AT 375338B
Authority
AT
Austria
Prior art keywords
acid addition
addition salts
producing new
new polypeptides
polypeptides
Prior art date
Application number
AT0634679A
Other languages
English (en)
Other versions
ATA634679A (de
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of ATA634679A publication Critical patent/ATA634679A/de
Application granted granted Critical
Publication of AT375338B publication Critical patent/AT375338B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/645Secretins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/66Thymopoietins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0819Tripeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1005Tetrapeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0634679A 1978-09-28 1979-09-27 Verfahren zur herstellung von neuen polypeptiden oder von deren saeureadditionssalzen AT375338B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK430478 1978-09-28

Publications (2)

Publication Number Publication Date
ATA634679A ATA634679A (de) 1983-12-15
AT375338B true AT375338B (de) 1984-07-25

Family

ID=8132257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0634679A AT375338B (de) 1978-09-28 1979-09-27 Verfahren zur herstellung von neuen polypeptiden oder von deren saeureadditionssalzen

Country Status (16)

Country Link
US (1) US4356119A (de)
JP (2) JPS5576849A (de)
AT (1) AT375338B (de)
AU (2) AU526149B2 (de)
BE (2) BE879087A (de)
CA (2) CA1140116A (de)
CH (2) CH648568A5 (de)
DE (2) DE2939135A1 (de)
ES (2) ES484926A1 (de)
FI (2) FI68244C (de)
FR (2) FR2437399A1 (de)
GB (2) GB2031436B (de)
IT (2) IT1125421B (de)
NL (2) NL7907187A (de)
NO (2) NO148923C (de)
SE (2) SE7907938L (de)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA616330A (en) * 1961-03-14 Schwyzer Robert Polypeptide and derivatives thereof and process for their manfuacture
CA685075A (en) * 1964-04-21 Schwyzer Robert Polypeptides and process for their manufacture
CA798855A (en) * 1968-11-12 Bernardi Luigi Process for preparing a new undecapeptide
GB1064417A (en) * 1963-12-09 1967-04-05 Kyowa Hakko Kogyo Kk Process for the preparation of copolypeptides
US3400118A (en) * 1966-05-27 1968-09-03 Squibb & Sons Inc Intermediates in the preparation of secretin
US3832337A (en) * 1970-07-28 1974-08-27 Squibb & Sons Inc Peptide enzyme inhibitors
US3856770A (en) * 1972-03-08 1974-12-24 Akzona Inc Psychopharmacologically active tetra-, penta-, hexa-, and heptapeptides
NL175174C (nl) * 1972-03-31 1984-10-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175988C (nl) * 1972-05-24 1985-02-01 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat dat afgeleid is van een de aminozuren 4-10 omvattend, fragment van adrenocorticotroop hormoon als actief bestanddeel bevat, alsmede een werkwijze ter bereiding van deze peptiden.
NL175618C (nl) * 1972-07-15 1984-12-03 Akzo Nv Werkwijze ter bereiding van een farmaceutisch preparaat met psychofarmacologische werking, dat een peptide of peptide-derivaat bevat, alsmede een werkwijze ter bereiding van dergelijke peptiden.
DE2315271C3 (de) * 1973-03-27 1975-09-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen L- Norleucin-13-Motilin, Verfahren zu dessen Herstellung und dasselbe enthaltendes Mittel
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US3975365A (en) * 1975-01-27 1976-08-17 G. D. Searle & Co. Inhibitory octapeptides angiotensin II
DE2602443A1 (de) * 1975-04-04 1976-10-21 Univ California Biologisch aktive polypeptide
US4171299A (en) * 1975-04-04 1979-10-16 The Regents Of The University Of California Polypeptide agents for blocking the human allergic response
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
US4024121A (en) * 1976-01-27 1977-05-17 Schally Andrew Victor (Pyro)-Glu-His-Trp-D-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHR and intermediates
SE436645C (sv) * 1976-04-29 1996-07-22 Bonnierfoeretagen Ab Antigeniskt aktiv polypeptid, som kan användas vid cancerdiagnosticering och vid framställning av antikroppar
US4110321A (en) * 1976-07-12 1978-08-29 Folkers Karl Synthetic tridecapeptide [Gln4 ]-neurotensin having hormonal activity
US4086220A (en) * 1976-08-09 1978-04-25 G. D. Searle & Co. Fragments of secretin

Also Published As

Publication number Publication date
IT1125421B (it) 1986-05-14
US4356119A (en) 1982-10-26
CA1158640A (en) 1983-12-13
FR2437399B1 (de) 1983-01-28
SE7907939L (sv) 1980-03-29
JPS5569550A (en) 1980-05-26
CH648568A5 (de) 1985-03-29
AU533684B2 (en) 1983-12-08
DE2939109A1 (de) 1980-04-10
IT7926112A0 (it) 1979-09-28
IT1125422B (it) 1986-05-14
FI793002A7 (fi) 1980-03-29
ES484928A1 (es) 1980-07-01
FR2437400B1 (de) 1984-06-15
NO148922C (no) 1984-01-11
GB2031435B (en) 1982-11-10
SE7907938L (sv) 1980-03-29
CH648567A5 (de) 1985-03-29
FI793001A7 (fi) 1980-03-29
FI68244C (fi) 1985-08-12
AU5124579A (en) 1980-04-03
NO148923B (no) 1983-10-03
AU526149B2 (en) 1982-12-16
NL7907187A (nl) 1980-04-01
AU5124679A (en) 1980-04-03
ES484926A1 (es) 1980-07-01
NO793112L (no) 1980-03-31
NO148922B (no) 1983-10-03
BE879086A (fr) 1980-03-28
GB2031436B (en) 1982-10-20
NO148923C (no) 1984-01-11
FR2437399A1 (fr) 1980-04-25
FI68245B (fi) 1985-04-30
FR2437400A1 (fr) 1980-04-25
DE2939135A1 (de) 1980-04-17
ATA634679A (de) 1983-12-15
GB2031435A (en) 1980-04-23
FI68245C (fi) 1985-08-12
FI68244B (fi) 1985-04-30
JPS5576849A (en) 1980-06-10
NL7907188A (nl) 1980-04-01
NO793111L (no) 1980-03-31
IT7926111A0 (it) 1979-09-28
GB2031436A (en) 1980-04-23
BE879087A (fr) 1980-03-28
CA1140116A (en) 1983-01-25

Similar Documents

Publication Publication Date Title
AT373887B (de) Verfahren zur herstellung von neuen n-heterocyclyl-4-piperidinaminen und deren saeureadditionssalzen
AT374477B (de) Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
AT357143B (de) Verfahren zur herstellung von neuen substi- tuierten 3-phenoxy-2-hydroxy-1-aminopropanen sowie deren saeureadditionssalzen
AT368168B (de) Verfahren zur herstellung von neuen thioetiansaeurederivaten
AT362347B (de) Verfahren zur herstellung von neuen 3-phenoxy-3 -phenylpropanaminen sowie deren saeureadditions- salzen
AT361937B (de) Verfahren zur herstellung von neuen 4-acyl- aminophenyl-aethanolaminen und deren saeure- additionssalzen
AT366662B (de) Verfahren zur herstellung von neuen 1-aryloxy-3- nitratoalkylamino-2-propanolen und deren saeureadditionssalzen
ATA204479A (de) Verfahren zur herstellung von neuen n-oxacyclyl- alkyl-piperidyl-daizaverbindungen und von deren salzen
AT372085B (de) Verfahren zur herstellung von neuen substituierten diphenyl-imidazolyl-methanen und von deren salzen
AT369731B (de) Verfahren zur herstellung von neuen 4-pyridon-3-carbonsaeurederivaten und deren salzen
AT368490B (de) Verfahren zur herstellung von neuen alkylthio-phenoxy-alkylaminen sowie von deren saeureadditionssalzen
AT365564B (de) Verfahren zur herstellung von neuen alpha-phenylbenzylidenaminoalkansaeurederivaten
AT363923B (de) Verfahren zur herstellung von neuen 8-amino-alkyltetracyclononanen und von deren saeureadditionssalzen
AT372081B (de) Verfahren zur herstellung von neuen substituierten n-iminomethylpiperidinen und von deren saeureadditionssalzen
AT360033B (de) Verfahren zur herstellung von neuen tetrahydro- -s-triazinthionen und deren saeure- additionssalzen
AT351509B (de) Verfahren zur herstellung von neuen 3-phenoxy-2 -hydroxy-1-phenoxy- oder -1-phenylthioalkyl- amino-propanen und von deren saeureadditions- salzen
AT368155B (de) Verfahren zur herstellung von neuen vincamonsalzen
AT375338B (de) Verfahren zur herstellung von neuen polypeptiden oder von deren saeureadditionssalzen
ATA144581A (de) Verfahren zur herstellung von neuen phenylessig- saeure-derivaten und deren salzen
AT369740B (de) Verfahren zur herstellung von neuen thiodibenzthiepinen und deren saeureadditionssalzen
ATA144681A (de) Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen
ATA144781A (de) Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen
ATA144381A (de) Verfahren zur herstellung von neuen indan-1-carbonsaeure-derivaten und deren salzen
ATA305982A (de) Verfahren zur herstellung von neuen cycloalkyltriazolen und deren salzen
ATA48381A (de) Verfahren zur herstellung von neuen substituierten 4-sulfonylamino-phenoxyalkancarbonsaeure und deren derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee